Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion type Assertion NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_head.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion description "[VPY is a novel PepT1 substrate that can inhibit the production of pro-inflammatory mediators in vitro in intestinal epithelial and immune cells, and reduce the severity of colitis in mice by down-regulating the expression of pro-inflammatory cytokines in the colon, suggesting that VPY may be promising for the treatment of IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_provenance.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion evidence source_evidence_literature NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_provenance.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion SIO_000772 22842481 NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_provenance.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion wasDerivedFrom befree-2016 NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_provenance.
- NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_assertion wasGeneratedBy ECO_0000203 NP1001050.RAR0-FdSIMK3YRPJ0lTz0RbDMNbpYlr3T1zJbsKi1yXzU130_provenance.